TME Pharma awarded €2.4 million German federal grant to support NOX-A12 phase 2 trial in brain cancer
The grant program run by the German Federal Ministry of Education and Research (BMBF) supports SMEs working on innovative projects in biomedicine. Non-dilutive support for planned Phase 2 trial now totals over €7 million.